Revvity has received FDA clearance for its total testosterone automated ChLIA via its Immunodiagnostic Systems subsidiary.

UroMems plans to use the funds to complete a pivotal trial to support regulatory filings for its UroActive system in the US and Europe.

AngioDynamics has reported two-year data from the PRESERVE pivotal trial, showing durable outcomes for the NanoKnife IRE system in treating intermediate-risk prostate cancer.

The raise will support Rivermark’s pivotal trial on its FloStent device, which is in development to treat patients with an enlarged prostate.

J&J has globally launched its Shockwave C2 Aero coronary IVL catheter, which aims to help in the treatment of calcified CAD.

Following news that started brewing last week, Dr Marty Makary has officially resigned from his post as commissioner of the US Food and Drug Administration (FDA), with Kyle Diaman ...

The US Food and Drug Administration (FDA) has cleared Bayesian Health’s continuous artificial intelligence (AI)-driven sepsis monitor, making the device the first of its kind to ...

HeartBeam has commenced a pilot study to evaluate its on-demand 12-lead ECG patch in patients with suspected coronary artery disease.

Despite a patient death, WhiteSwell is moving forward with its plans to conduct the randomised LYMPH-HF trial on its eLym system in ADHF.

SQ Innovation’s topline data evaluating its Lasix Onyu home care oedema treatment versus SoC IV was shared at the 2026 Heart Failure Congress in Barcelona.

Ahead of Biomed Israel, Chaim Lotan discusses how innovation in cardiovascular medicine is evolving toward more precise, personalised treatment approaches.

According to a report by Barnes & Thornburg, the Department of Justice (DoJ) is clamping down on fraud across the healthcare industry.